- Filed
- May 3, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 22, 2024 | 173M sh |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $1.66B |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $1.68B |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $552M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $540M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $3.15B |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $3.25B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $1.58B |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $1.17B |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $4.18B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.77B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $2.44B |
| Current Assets | Q1 2024 · Dec 31, 2023 | $2.31B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $7.57B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $7.25B |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 184.4M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $97M |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $44M |
| Capex | Q1 2024 · Mar 31, 2023 | $46M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$154M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.83 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.84 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $188M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $30M |
| Net Income | Q1 2024 · Mar 31, 2023 | $153M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $61M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $269M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $1.34B |
| Revenue | Q1 2024 · Mar 31, 2023 | $1.61B |